Tag Archives: amfAR

World AIDS Day 2014: Focus, Partner, Achieve: An AIDS-free Generation

World AIDS day, commemorated each year on Dec 1, aims to raise awareness about the virus, encourage advocates to redouble efforts to fight the epidemic, and remember those who have died and continue to suffer from the disease.

Photo credit: cdc.gov

Photo credit: cdc.gov

The 2014 World AIDS day theme “Focus, Partner, Achieve: An AIDS-free Generation,” speaks to how combined efforts and collaborations can bring us closer to a cure or vaccine. For example, public and private-sector funded research led to the development of Highly Active Antiretroviral Therapy (HAART), which revolutionized the battle against HIV/AIDS according to Research!America’s HIV/AIDS fact sheet.

Medical research has played a critical role in reducing the risk of transmission and has led to new drugs that have transformed HIV/AIDS from a fatal to a chronic illness for millions worldwide. Patients like Maria Davis, professional entertainer and HIV/AIDS advocate, has benefited from advances in HIV/AIDS treatments.

Research!America member, amfAR, The Foundation for AIDS research and The Centers for Disease Control and Prevention are raising awareness on World AIDS Day by providing up-to-date resources and information describing the human and economic impact of HIV/AIDS. In FY14, U.S. federal funding to combat HIV/AIDS here and abroad and assist those affected by the disease totaled $29.5 billion, but more resources and funding are needed to tackle this global epidemic. Tell Congress that we need more funding for HIV/AIDS research today!

To find out more about the events happening on Dec. 1, visit http://aids.gov/

Advertisements

amfAR Analysis: Sequestration for Global Health Programs Isn’t Worth the Cost

A graphic from a recent amfAR report shows the potential loss of life because of across-the-board cuts, or sequestration.

Research!America’s report on sequestration detailed the devastating impact that the sequester, or across-the-board cuts that are scheduled to take place in 2013, will have on federally funded research to improve health. Now, a recent report by amfAR trains the focus of sequestration on global health.

Just as we found, amfAR reaches the same conclusion: Sequestration isn’t worth the cost.

The cuts would save $689 million — or 0.63% of the required deficit reduction for FY13. And at what cost?

  • HIV/AIDS treatment for 273,000 fewer people, potentially leading to 62,000 more deaths
  • Malaria treatment for 3.7 million fewer people, potentially leading to nearly 6,000 more deaths
  • TB treatment for 65,000 fewer people, potentially leading to 8,000 more deaths
  • Reduced funding for the GAVI Alliance, potentially resulting in 13,000 more deaths from diptheria, tetanus, pertussis, hib and hepatitis B

That’s hardly all. Besides an increase in the death rate, critical interventions will never get a chance to prevent disease: antiretroviral drugs that prevent transmission of HIV from a pregnant mother to her child and insecticide-treated nets to prevent bites from malaria-infected mosquitoes.

And that has consequences further down the line, the report notes.

“The savings achieved in across-the-board cuts in global health funding will have a negligible impact on deficit reduction,” the report states, “but will adversely affect the lives of millions of men, women and children worldwide, resulting in substantial human suffering and squandering of opportunities to build on successes in U.S. global health programming.”

Your voice can make a difference, however. Click here to contact your representatives, and tell them that sequestration is an unacceptable outcome.

Download the full amfAR report here.

amfAR is a Research!America member.